Thomas A - Search Results

1

Duration of amantadine benefit on dyskinesia of severe Parkinson's disease.

Thomas A, Iacono D, Luciano AL, Armellino K, Di Iorio A, Onofrj M. Thomas A, et al. J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):141-3. J Neurol Neurosurg Psychiatry. 2004. PMID: 14707325 Free PMC article. Clinical Trial.

2

One further case of pancytopenia induced by olanzapine in a Parkinson's disease patient.

Onofrj M, Thomas A. Onofrj M, et al. Among authors: thomas a. Eur Neurol. 2001;45(1):56-7. doi: 10.1159/000052093. Eur Neurol. 2001. PMID: 11150845 No abstract available.

3

Switch-over from tolcapone to entacapone in severe Parkinson's disease patients.

Onofrj M, Thomas A, Iacono D, Di Iorio A, Bonanni L. Onofrj M, et al. Among authors: thomas a. Eur Neurol. 2001;46(1):11-6. doi: 10.1159/000050749. Eur Neurol. 2001. PMID: 11455177

4

Amantadine for dyskinesia in patients affected by severe Parkinson's disease.

Paci C, Thomas A, Onofrj M. Paci C, et al. Among authors: thomas a. Neurol Sci. 2001 Feb;22(1):75-6. doi: 10.1007/s100720170054. Neurol Sci. 2001. PMID: 11487209 Clinical Trial.

5

Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism.

Onofrj M, Luciano AL, Thomas A, Iacono D, D'Andreamatteo G. Onofrj M, et al. Among authors: thomas a. Neurology. 2003 Jan 14;60(1):113-5. doi: 10.1212/01.wnl.0000042084.03066.c0. Neurology. 2003. PMID: 12525729

6

Acute akinesia or akinetic crisis in Parkinson's disease.

Thomas A, Iacono D, Luciano AL, Armellino K, Onofrj M. Thomas A, et al. Neurol Sci. 2003 Oct;24(3):219-20. doi: 10.1007/s10072-003-0139-6. Neurol Sci. 2003. PMID: 14598096

7

Clinically evidenced unilateral dissociation of saccades and pursuit eye movements.

Onofrj M, Iacono D, Luciano AL, Armellino K, Thomas A. Onofrj M, et al. Among authors: thomas a. J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):1048-50. doi: 10.1136/jnnp.2003.025163. J Neurol Neurosurg Psychiatry. 2004. PMID: 15201370 Free PMC article.

8

Improvement of motor function in early Parkinson disease by safinamide.

Stocchi F, Arnold G, Onofrj M, Kwiecinski H, Szczudlik A, Thomas A, Bonuccelli U, Van Dijk A, Cattaneo C, Sala P, Fariello RG; Safinamide Parkinson's Study Group. Stocchi F, et al. Among authors: thomas a. Neurology. 2004 Aug 24;63(4):746-8. doi: 10.1212/01.wnl.0000134672.44217.f7. Neurology. 2004. PMID: 15326260 Clinical Trial.

9

Gabapentin in orthostatic tremor: results of a double-blind crossover with placebo in four patients.

Onofrj M, Thomas A, Paci C, D'Andreamatteo G. Onofrj M, et al. Among authors: thomas a. Neurology. 1998 Sep;51(3):880-2. doi: 10.1212/wnl.51.3.880. Neurology. 1998. PMID: 9748048 Clinical Trial.

10

Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease.

Onofrj M, Paci C, Thomas A. Onofrj M, et al. Among authors: thomas a. J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):605-6. doi: 10.1136/jnnp.65.4.605. J Neurol Neurosurg Psychiatry. 1998. PMID: 9771801 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,902 results

Search Page

Filters